Fixed dose rate (FDR) gemcitabine (G) and capecitabine (C) in patients with advanced and/or metastatic cancer: phase I trial

Donatella Santini,B. Vincenzi,Vladimir Virzì,A. La Cesa,Gaia Schiavon,V. Leoni,Simona Gasparro,Claudia Grilli,Alice Calvieri,G. Tonini

Fixed dose rate (FDR) gemcitabine (G) and capecitabine (C) in patients with advanced and/or metastatic cancer: phase I trial

2006

Donatella Santini
B. Vincenzi
Vladimir Virzì
A. La Cesa
Gaia Schiavon
V. Leoni
Simona Gasparro
Claudia Grilli
Alice Calvieri
G. Tonini

12016 Background: Combination of C and G has been demonstrated to be well tolerated, with apparent efficacy in patients with advanced cancers. To determine the toxicity of C plus Fixed Dose Rate (F...

Keywords:

Capecitabine
Gemcitabine
Cancer
Cancer research
Oncology
Medicine
Internal medicine
fixed dose rate
in patient
Toxicity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations